DeepMed Research

UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Phase 2

Completed

Conditions: Neurofibromatosis Type 1

Interventions: Drug: Sirolimus

First Posted Date: 2008-03-13

Last Posted Date: 2017-11-17

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 58

Registration Number: NCT00634270

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States

and more 6 locations

Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin

Phase 2

Completed

Conditions: Invasive Breast Cancer

Interventions: Drug: Doxil, Paclitaxel, Cyclophosphamide, Avastin

First Posted Date: 2008-03-13

Last Posted Date: 2016-07-14

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 32

Registration Number: NCT00635050

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Dental Tobacco Control.Net:Improving Practice

Early Phase 1

Completed

Conditions: Tobacco Use Disorder

Interventions: Behavioral: Internet-delivered continuing professional development
Other: No intervention arm

First Posted Date: 2008-02-29

Last Posted Date: 2015-03-09

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 190

Registration Number: NCT00627185

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia

Phase 4

Completed

Conditions: ADHD With Sleep Onset Insomnia

Interventions: Drug: Placebo
Drug: Ramelteon

First Posted Date: 2008-02-25

Last Posted Date: 2013-05-24

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 32

Registration Number: NCT00622427

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

ADAPT-Altering Diet for African American Populations to Treat Hypertension

Not Applicable

Completed

Conditions: Hypertension

Interventions: Behavioral: Intervention with no dietary component - information regarding useful life skills
Behavioral: Dietary Approaches to Stop Hypertension-The DASH diet

First Posted Date: 2008-02-22

Last Posted Date: 2013-03-18

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 122

Registration Number: NCT00621569

Locations: 🇺🇸
University of Alabama at Birmingham Department of Nutrition Sciences, Birmingham, Alabama, United States

Identification of Genetic Markers for Cardiopulmonary Diseases (Genotype)

Completed

Conditions: Cardiovascular Diseases

First Posted Date: 2008-02-15

Last Posted Date: 2016-01-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 255

Registration Number: NCT00616369

Locations: 🇺🇸
University of Alabama @ Birmingham, Birmingham, Alabama, United States

BLYS and IFN in SLE

Completed

Conditions: Systemic Lupus Erythematosus

Interventions: Biological: fluzone
Biological: pneumovax

First Posted Date: 2008-02-11

Last Posted Date: 2011-04-28

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 39

Registration Number: NCT00611611

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

Completed

Conditions: Pancreatitis
Gallbladder Disease

First Posted Date: 2008-02-07

Last Posted Date: 2016-01-25

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 199

Registration Number: NCT00609726

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States

Complementary and Alternative Medicine for Urological Symptoms(CAMUS)

Phase 3

Completed

Conditions: Urological

Interventions: Drug: Saw Palmetto - first 24 weeks
Drug: Placebo - first 24 weeks
Drug: Placebo - weeks 24 - 48
Drug: Saw Palmetto - weeks 24 - 48
Drug: Placebo - weeks 48 - 72
Drug: Saw Palmetto - weeks 48 - 72

First Posted Date: 2008-01-29

Last Posted Date: 2012-10-12

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 369

Registration Number: NCT00603304

Locations: 🇺🇸
University of Texas - Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
New York University, New York, New York, United States
🇺🇸
University of Maryland, Baltimore, Maryland, United States

and more 8 locations

Low Cost Interventions to Improve Adherence to Childhood Immunization Schedule

Not Applicable

Completed

Conditions: Childhood Immunization Dropout
Immunization Card
Childhood Immunization Completion
Center Based Education

Interventions: Other: Center based education to mothers/caregivers
Other: Redesigned immunization card with center based education to mother/caregivers
Other: Redesigned immunization card

First Posted Date: 2008-01-28

Last Posted Date: 2008-01-28

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 1506

Registration Number: NCT00602056

Locations: 🇵🇰
EPI immunization centers, Karachi, Sindh, Pakistan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy